Global Cell-Free DNA (cfDNA) Testing Market Insights and Forecast to 2031

Report ID: 1665326 | Published Date: Jan 2025 | No. of Page: 111 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Donor-Derived Cell-Free DNA (DdcfDNA)
        1.2.3 Circulating Cell-Free Tumor DNA (CtDNA)
        1.2.4 Cell-Free Fetal DNA (NIPT)
    1.3 Market by Application
        1.3.1 Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Cancer Research Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cell-Free DNA (cfDNA) Testing Market Perspective (2017-2028)
    2.2 Cell-Free DNA (cfDNA) Testing Growth Trends by Region
        2.2.1 Cell-Free DNA (cfDNA) Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cell-Free DNA (cfDNA) Testing Historic Market Size by Region (2017-2022)
        2.2.3 Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Region (2023-2028)
    2.3 Cell-Free DNA (cfDNA) Testing Market Dynamics
        2.3.1 Cell-Free DNA (cfDNA) Testing Industry Trends
        2.3.2 Cell-Free DNA (cfDNA) Testing Market Drivers
        2.3.3 Cell-Free DNA (cfDNA) Testing Market Challenges
        2.3.4 Cell-Free DNA (cfDNA) Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue
        3.1.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue (2017-2022)
        3.1.2 Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cell-Free DNA (cfDNA) Testing Revenue
    3.4 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio
        3.4.1 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cell-Free DNA (cfDNA) Testing Revenue in 2021
    3.5 Cell-Free DNA (cfDNA) Testing Key Players Head office and Area Served
    3.6 Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
    3.7 Date of Enter into Cell-Free DNA (cfDNA) Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Free DNA (cfDNA) Testing Breakdown Data by Type
    4.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Type (2017-2022)
    4.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2023-2028)
5 Cell-Free DNA (cfDNA) Testing Breakdown Data by Application
    5.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Application (2017-2022)
    5.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cell-Free DNA (cfDNA) Testing Market Size (2017-2028)
    6.2 North America Cell-Free DNA (cfDNA) Testing Market Size by Type
        6.2.1 North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022)
        6.2.2 North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2023-2028)
        6.2.3 North America Cell-Free DNA (cfDNA) Testing Market Share by Type (2017-2028)
    6.3 North America Cell-Free DNA (cfDNA) Testing Market Size by Application
        6.3.1 North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022)
        6.3.2 North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2023-2028)
        6.3.3 North America Cell-Free DNA (cfDNA) Testing Market Share by Application (2017-2028)
    6.4 North America Cell-Free DNA (cfDNA) Testing Market Size by Country
        6.4.1 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2017-2022)
        6.4.2 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Cell-Free DNA (cfDNA) Testing Market Size (2017-2028)
    7.2 Europe Cell-Free DNA (cfDNA) Testing Market Size by Type
        7.2.1 Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022)
        7.2.2 Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2023-2028)
        7.2.3 Europe Cell-Free DNA (cfDNA) Testing Market Share by Type (2017-2028)
    7.3 Europe Cell-Free DNA (cfDNA) Testing Market Size by Application
        7.3.1 Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022)
        7.3.2 Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2023-2028)
        7.3.3 Europe Cell-Free DNA (cfDNA) Testing Market Share by Application (2017-2028)
    7.4 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country
        7.4.1 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2017-2022)
        7.4.2 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size (2017-2028)
    8.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Type
        8.2.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Share by Type (2017-2028)
    8.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Application
        8.3.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Share by Application (2017-2028)
    8.4 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region
        8.4.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size (2017-2028)
    9.2 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type
        9.2.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022)
        9.2.2 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type (2023-2028)
        9.2.3 Latin America Cell-Free DNA (cfDNA) Testing Market Share by Type (2017-2028)
    9.3 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application
        9.3.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022)
        9.3.2 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application (2023-2028)
        9.3.3 Latin America Cell-Free DNA (cfDNA) Testing Market Share by Application (2017-2028)
    9.4 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country
        9.4.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2017-2022)
        9.4.2 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size (2017-2028)
    10.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Type
        10.2.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Share by Type (2017-2028)
    10.3 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Application
        10.3.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Share by Application (2017-2028)
    10.4 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country
        10.4.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Agilent Technology
        11.1.1 Agilent Technology Company Details
        11.1.2 Agilent Technology Business Overview
        11.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Introduction
        11.1.4 Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.1.5 Agilent Technology Recent Developments
    11.2 Allenex
        11.2.1 Allenex Company Details
        11.2.2 Allenex Business Overview
        11.2.3 Allenex Cell-Free DNA (cfDNA) Testing Introduction
        11.2.4 Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.2.5 Allenex Recent Developments
    11.3 Biocept
        11.3.1 Biocept Company Details
        11.3.2 Biocept Business Overview
        11.3.3 Biocept Cell-Free DNA (cfDNA) Testing Introduction
        11.3.4 Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.3.5 Biocept Recent Developments
    11.4 Biodesix
        11.4.1 Biodesix Company Details
        11.4.2 Biodesix Business Overview
        11.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Introduction
        11.4.4 Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.4.5 Biodesix Recent Developments
    11.5 CareDx
        11.5.1 CareDx Company Details
        11.5.2 CareDx Business Overview
        11.5.3 CareDx Cell-Free DNA (cfDNA) Testing Introduction
        11.5.4 CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.5.5 CareDx Recent Developments
    11.6 Guardant Health
        11.6.1 Guardant Health Company Details
        11.6.2 Guardant Health Business Overview
        11.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Introduction
        11.6.4 Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.6.5 Guardant Health Recent Developments
    11.7 Illumania
        11.7.1 Illumania Company Details
        11.7.2 Illumania Business Overview
        11.7.3 Illumania Cell-Free DNA (cfDNA) Testing Introduction
        11.7.4 Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.7.5 Illumania Recent Developments
    11.8 Invited
        11.8.1 Invited Company Details
        11.8.2 Invited Business Overview
        11.8.3 Invited Cell-Free DNA (cfDNA) Testing Introduction
        11.8.4 Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.8.5 Invited Recent Developments
    11.9 Natera
        11.9.1 Natera Company Details
        11.9.2 Natera Business Overview
        11.9.3 Natera Cell-Free DNA (cfDNA) Testing Introduction
        11.9.4 Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.9.5 Natera Recent Developments
    11.10 Quest Diagnostics
        11.10.1 Quest Diagnostics Company Details
        11.10.2 Quest Diagnostics Business Overview
        11.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Introduction
        11.10.4 Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.10.5 Quest Diagnostics Recent Developments
    11.11 Roche Holdings
        11.11.1 Roche Holdings Company Details
        11.11.2 Roche Holdings Business Overview
        11.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Introduction
        11.11.4 Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.11.5 Roche Holdings Recent Developments
    11.12 Sequenom
        11.12.1 Sequenom Company Details
        11.12.2 Sequenom Business Overview
        11.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Introduction
        11.12.4 Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.12.5 Sequenom Recent Developments
    11.13 Trovagene
        11.13.1 Trovagene Company Details
        11.13.2 Trovagene Business Overview
        11.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Introduction
        11.13.4 Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
        11.13.5 Trovagene Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Donor-Derived Cell-Free DNA (DdcfDNA)
    Table 3. Key Players of Circulating Cell-Free Tumor DNA (CtDNA)
    Table 4. Key Players of Cell-Free Fetal DNA (NIPT)
    Table 5. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2017-2022)
    Table 9. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2023-2028)
    Table 11. Cell-Free DNA (cfDNA) Testing Market Trends
    Table 12. Cell-Free DNA (cfDNA) Testing Market Drivers
    Table 13. Cell-Free DNA (cfDNA) Testing Market Challenges
    Table 14. Cell-Free DNA (cfDNA) Testing Market Restraints
    Table 15. Global Cell-Free DNA (cfDNA) Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Players (2017-2022)
    Table 17. Global Top Cell-Free DNA (cfDNA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2021)
    Table 18. Ranking of Global Top Cell-Free DNA (cfDNA) Testing Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
    Table 22. Date of Enter into Cell-Free DNA (cfDNA) Testing Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2017-2022)
    Table 26. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2023-2028)
    Table 28. Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Application (2017-2022)
    Table 30. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Application (2023-2028)
    Table 32. North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Cell-Free DNA (cfDNA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Cell-Free DNA (cfDNA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Cell-Free DNA (cfDNA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Cell-Free DNA (cfDNA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Agilent Technology Company Details
    Table 63. Agilent Technology Business Overview
    Table 64. Agilent Technology Cell-Free DNA (cfDNA) Testing Product
    Table 65. Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 66. Agilent Technology Recent Developments
    Table 67. Allenex Company Details
    Table 68. Allenex Business Overview
    Table 69. Allenex Cell-Free DNA (cfDNA) Testing Product
    Table 70. Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 71. Allenex Recent Developments
    Table 72. Biocept Company Details
    Table 73. Biocept Business Overview
    Table 74. Biocept Cell-Free DNA (cfDNA) Testing Product
    Table 75. Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 76. Biocept Recent Developments
    Table 77. Biodesix Company Details
    Table 78. Biodesix Business Overview
    Table 79. Biodesix Cell-Free DNA (cfDNA) Testing Product
    Table 80. Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 81. Biodesix Recent Developments
    Table 82. CareDx Company Details
    Table 83. CareDx Business Overview
    Table 84. CareDx Cell-Free DNA (cfDNA) Testing Product
    Table 85. CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 86. CareDx Recent Developments
    Table 87. Guardant Health Company Details
    Table 88. Guardant Health Business Overview
    Table 89. Guardant Health Cell-Free DNA (cfDNA) Testing Product
    Table 90. Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 91. Guardant Health Recent Developments
    Table 92. Illumania Company Details
    Table 93. Illumania Business Overview
    Table 94. Illumania Cell-Free DNA (cfDNA) Testing Product
    Table 95. Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 96. Illumania Recent Developments
    Table 97. Invited Company Details
    Table 98. Invited Business Overview
    Table 99. Invited Cell-Free DNA (cfDNA) Testing Product
    Table 100. Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 101. Invited Recent Developments
    Table 102. Natera Company Details
    Table 103. Natera Business Overview
    Table 104. Natera Cell-Free DNA (cfDNA) Testing Product
    Table 105. Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 106. Natera Recent Developments
    Table 107. Quest Diagnostics Company Details
    Table 108. Quest Diagnostics Business Overview
    Table 109. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product
    Table 110. Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 111. Quest Diagnostics Recent Developments
    Table 112. Roche Holdings Company Details
    Table 113. Roche Holdings Business Overview
    Table 114. Roche Holdings Cell-Free DNA (cfDNA) Testing Product
    Table 115. Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 116. Roche Holdings Recent Developments
    Table 117. Sequenom Company Details
    Table 118. Sequenom Business Overview
    Table 119. Sequenom Cell-Free DNA (cfDNA) Testing Product
    Table 120. Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 121. Sequenom Recent Developments
    Table 122. Trovagene Company Details
    Table 123. Trovagene Business Overview
    Table 124. Trovagene Cell-Free DNA (cfDNA) Testing Product
    Table 125. Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2017-2022) & (US$ Million)
    Table 126. Trovagene Recent Developments
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cell-Free DNA (cfDNA) Testing Market Share by Type: 2021 VS 2028
    Figure 2. Donor-Derived Cell-Free DNA (DdcfDNA) Features
    Figure 3. Circulating Cell-Free Tumor DNA (CtDNA) Features
    Figure 4. Cell-Free Fetal DNA (NIPT) Features
    Figure 5. Global Cell-Free DNA (cfDNA) Testing Market Share by Application: 2021 VS 2028
    Figure 6. Hospital Case Studies
    Figure 7. Ambulatory Surgical Centers Case Studies
    Figure 8. Cancer Research Institutes Case Studies
    Figure 9. Cell-Free DNA (cfDNA) Testing Report Years Considered
    Figure 10. Global Cell-Free DNA (cfDNA) Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Cell-Free DNA (cfDNA) Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Cell-Free DNA (cfDNA) Testing Market Share by Region: 2021 VS 2028
    Figure 13. Global Cell-Free DNA (cfDNA) Testing Market Share by Players in 2021
    Figure 14. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue in 2021
    Figure 16. North America Cell-Free DNA (cfDNA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Cell-Free DNA (cfDNA) Testing Market Size Market Share by Type (2017-2028)
    Figure 18. North America Cell-Free DNA (cfDNA) Testing Market Size Market Share by Application (2017-2028)
    Figure 19. North America Cell-Free DNA (cfDNA) Testing Market Size Share by Country (2017-2028)
    Figure 20. United States Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Cell-Free DNA (cfDNA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Cell-Free DNA (cfDNA) Testing Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Cell-Free DNA (cfDNA) Testing Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Cell-Free DNA (cfDNA) Testing Market Size Share by Country (2017-2028)
    Figure 26. Germany Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size Share by Region (2017-2028)
    Figure 36. China Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Cell-Free DNA (cfDNA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Cell-Free DNA (cfDNA) Testing Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Cell-Free DNA (cfDNA) Testing Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Cell-Free DNA (cfDNA) Testing Market Size Share by Country (2017-2028)
    Figure 46. Mexico Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size Share by Country (2017-2028)
    Figure 52. Turkey Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Agilent Technology Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 56. Allenex Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 57. Biocept Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 58. Biodesix Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 59. CareDx Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 60. Guardant Health Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 61. Illumania Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 62. Invited Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 63. Natera Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 64. Quest Diagnostics Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 65. Roche Holdings Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 66. Sequenom Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 67. Trovagene Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche Holdings
Sequenom
Trovagene
Frequently Asked Questions
Cell-Free DNA (cfDNA) Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cell-Free DNA (cfDNA) Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cell-Free DNA (cfDNA) Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Cellular Imaging

Cellular Imaging market is segmented by players, region (country), by Type and by Application. Pl ... Read More

Cellulose Paints

Cellulose Paints market is segmented by Type and by Application. Players, stakeholders, and other ... Read More